About

cdifflogoadjdtrd The C Diff Foundation was founded in 2012 and is comprised of 100% Volunteers dedicated in providing education and advocating for C. diff. Infection prevention, treatments, environmental safety with support worldwide.

Our Founder,a Nurse, was diagnosed, and treated repeatedly. In 2008 a prolonged CDI with Physicians last resort was a referral to Hospice,  then a new CDI diagnosis in 2011, each for a year’s length of treatment, many rounds of antibiotics and survived this horrible infection. From the two journeys, and witnessing their Father passing away from C. difficiile infection involvement, it confirmed the necessity to promote Clostridium difficile (C. diff.) infection awareness through educating, advocating  and presenting scientific research data provided by Government agencies, healthcare professionals and researchers, with environmental safety organizations worldwide.

cdiff2016newreleadephoto

An excerpt from USA Today article published in 2012:    Deaths and illnesses are much higher than reports have shown. In March, the  CDC  said in a report that the C difficile infection kills 14,000 people a year. But that estimate is based on death certificates, which often don’t list the infection when patients die from complications, such as kidney failure.  Hospital billing data collected by the federal Agency for Healthcare Research and Quality shows that more than 9% of C. diff-related hospitalizations end in death — nearly five times the rate for other hospital stays. That adds up to more than 30,000 fatalities among the 347,000 C. diff hospitalizations in 2010. Thousands more patients are treated in nursing homes, clinics and doctors’ offices.

“We’re talking in the range of close to 500,000 total cases a year,” says Cliff McDonald, a C. diff expert and senior science adviser in the CDC’s Division of Healthcare Quality Promotion. And annual fatalities “may well be … as high as 30,000.”

* AHRQ News and Numbers provides statistical highlights on the use and cost of health services and health insurance in the United States.

http://archive.ahrq.gov/news/newsroom/news-and-numbers/012512.html

This is sound evidence and gives concrete reason why the C Diff Foundation continues with the  Mission in Educating, and advocating for C difficile infection prevention, treatments, and environmental safety worldwide.

The Foundation’s  mission is dedicated at reaching out to medical practitioners, medical students, C. diff. survivors, caregivers, and patients combating a  C. difficile  infection (CDI) while providing the general public important information on prevention, treatments available, and EPA registered products available for environmental safety. We continue moving forward setting up outreach centers and building  positive networks with the C Diff Foundation  Volunteer Advocates aiding in “Raising C Diff Awareness” worldwide.

If you have questions, and would like to register to join the C Diff Foundation Volunteer Advocate Program or wish to help us extend the outreach of the C Diff Foundation please contact us:

Office Hours: 8:00 a.m. to 5:00 p.m. EST, Monday-Friday

Office #: 1-844-367-2343

EMAIL:   info@cdifffoundation.org

 

 

C Diff Foundation Board of Directors

Nancy C Caralla, Founding Executive Director, President
Scott Battles, Vice President
Dr. Ahmed A. M. Al Mandalawi, MD, Medical Director
Dolores Labita,  Secretary
Rowaland R. Dory, Vice Chair
Angelo Ortiz, Treasurer

—————————————————————————-

C Diff Foundation Committees cdiffreleasehorizontal-2

 

 

 

Mental Health Advisory Committee
Lesa Bridges, LCSW, MSW, Chairperson

Research and Development Committee
Dr. Martha R. Clokie, MS, PhD
Dr. Simon Cutting, MS,PhD, Chairperson
Dr. David Cook, MS, PhD

Medical Advisory Board
Dr. Mark Wilcox, MD, Chairperson
Dr. Barbara McGovern, MD
Dr. Rosie Lyles, MD

C. diff. Global Community Support Program
Dr. Paul Feuerstadt, MD, Co-Director
Dr. Caterina Oneto, MD, Co-Director
Scott Battles –  Support Leader
Karen Factor, RD-  Support Leader
Roy Poole –  Support Leader

C Diff Foundation Volunteer Patient Advocate Program
Angelo Ortiz, Chairperson
Lisa Hurka-Covington –  Innovative Team Management

Administrative Support Committee
Josh Factor, Fundraising/Grant Writing Development Coordinator
Scott Bauer, Administrative Support Intern

Marketing and Graphic Arts Committee
Joel Davis, BS, Chairperson

Global Community Education & Outreach Programs
Linda Jablonski, MS, BSN, RN-BC – Director Of Nursing

Nutrition and Wellness Committee
Karen Factor, RD, MS, Chairperson
Barley Chironda, RPN, CIC, Infection Prevention Advocate
Ron Romano, RN, Infection Prevention Advocate
Michele Martello, Wellness Advocate

Biologic Research and Development Committee
Michael Kaleko, MD, PhD, Senior Vice President, Reseaerch & Development Synthetic Biologics
Joseph Sliman, MD, MPH, Chief Medical Officer, Synthetic Biolgics
Andy Bristol, PhD, Vice President, Research & Development, Synthetic Biologics

 

Clinical Education Committee
Dr. Hudson Garrett, Jr., PhD, MSN, MPH, FNP, CSRN, VA-BC, CDONA,FACONA,DON-CLTC™, C-NAC™, PLNC, Chairman

 

CONTACT INFORMATION:

Main Office:  6931 Ian Court, #14,  New Port Richey, FL 34653  USA

Phone:           (919) 201-1512

Email:             info@cdifffoundation.org